RE: Jhfh12 Oct 2023 13:43
Mr India is doing a much better job than me of articulating, good job!
As for delays, we have already had delays, much more than we wanted or expected, none of us are happy about it, I am not going to lie and say I love that we are in Q4 of 2023 when I invested over 5 years ago expecting CDX to be in trials within 18 months. But in that time apart from Eli deciding not to buy it there and then and a really stupid CLN decision, by and large the company has grown and done very very well.
Completely agree, nothing is YET in clinical trials nothing has yet been licenced, but there are so many POTENTIAL updates that are just huge how can you walk away? Emotionally, how can you be happy with Hemogenyx? But in terms of raw potential for return on investment? It literally needs one good update, which we know will come, just not when, ANY of these would be monumental and any are possible:
CAR-T : IND Approved / Clinical Hold Lifted / Start of trials
CBR : Test results against live virus / in fact any good live results / Public confirmation of brain cancer / details about new subsidiory BAIT / Details about investment in to BAIT
CDX : Licence FINALLY getting signed after all this time / IND application
Generic : BARDA Funding / support, Grants, further strategic investment from Prevail
Any of these could land, we know the FDA are happy with the CH lifting plan and we know Prevail have faith that Hemogenyx can deliver it and are going to run the trials and we know they were targeting 2023 to start the trials. We know BAIT is real and Vlad + Prevail are inviting strategic investment outside of normal discount public placing we have had in the past. We know Hemo have been talking to interested parties about CDX, none of this is guess work its ALL significant. Just one is needed. One good bit of news, does not mean people have to be happy about how long its taken or about the share price, but letting emotions dictate how you trade is asking to lose.